WisdomTree BioRevolution Ownership
| WDNA Etf | USD 14.14 0.08 0.57% |
WisdomTree | Build AI portfolio with WisdomTree Etf |
WisdomTree Etf Ownership Analysis
WisdomTree BioRevolution is is formed as Regulated Investment Company in the United States. ETF is managed and operated by State Street Bank and Trust Company. The fund has 101 constituents across multiple sectors and instustries. The fund charges 0.45 percent management fee with a total expences of 0.45 percent of total asset. The fund keeps all of net assets in stocks. The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. Wisdomtree Biorevolution is traded on BATS Exchange in the United States. For more information please call the company at NA.Sector Exposure (%)
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on WisdomTree Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding WisdomTree BioRevolution , and the less return is expected.
Currency Exposure (%)
Investment Allocations (%)
Top Etf Constituents
| A | Agilent Technologies | Stock | |
| AGEN | Agenus Inc | Stock | |
| BIIB | Biogen Inc | Stock | |
| DHR | Danaher | Stock | |
| EDIT | Editas Medicine | Stock | |
| ILMN | Illumina | Stock | |
| LLY | Eli Lilly and | Stock | |
| RGEN | Repligen | Stock | |
| TMO | Thermo Fisher Scientific | Stock | |
| ZTS | Zoetis Inc | Stock |
WisdomTree BioRevolution Outstanding Bonds
WisdomTree BioRevolution issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. WisdomTree BioRevolution uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most WisdomTree bonds can be classified according to their maturity, which is the date when WisdomTree BioRevolution has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether WisdomTree BioRevolution offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of WisdomTree BioRevolution's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Wisdomtree Biorevolution Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Wisdomtree Biorevolution Etf:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in WisdomTree BioRevolution. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
The market value of WisdomTree BioRevolution is measured differently than its book value, which is the value of WisdomTree that is recorded on the company's balance sheet. Investors also form their own opinion of WisdomTree BioRevolution's value that differs from its market value or its book value, called intrinsic value, which is WisdomTree BioRevolution's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because WisdomTree BioRevolution's market value can be influenced by many factors that don't directly affect WisdomTree BioRevolution's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between WisdomTree BioRevolution's value and its price as these two are different measures arrived at by different means. Investors typically determine if WisdomTree BioRevolution is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WisdomTree BioRevolution's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.